Capital Appropriations

One man’s plan for high-concept health care legislation.

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


After watching the city’s spending on drugs for Medicaid recipients and municipal employees rise 256 percent during his seven-year tenure, Washington, D.C., City Council member David Catania came up with a plan for high-concept health care legislation. His law? That the city can invoke eminent domain over drug patents, then make the drugs available as cheaper generics.

It’s not as far-fetched as it sounds. For decades, the United States has used eminent domain to issue compulsory licenses in the defense industry. Patent holders get “just compensation” —such as the 1 percent royalty Hughes Aircraft made on its satellite technology after the courts ruled that 15 percent, or $3.3 billion, was excessive. The same could happen in health care. During the 2001 anthrax scare, Health and Human Services Secretary Tommy Thompson threatened to ignore Bayer’s Cipro patent to get hold of a cheaper generic; Bayer ended up boosting production and cutting the price.

Under pressure from businesses, Catania was undaunted. He rewrote the measure, minus the eminent domain language, and instead drew on the city’s powers to protect consumers. On a first vote, the council unanimously supported the new bill, which would allow residents to sue a drug company for “excessive prices,” when compared with those in Canada and elsewhere. If he can win this one in a final vote this summer—a big if, we know, since many great artists enjoy little success during their lifetimes—and a judge rules a drug is too pricey, the court could issue a compulsory license, authorizing the city to turn to another manufacturer.

Plus, Catania’s idea isn’t just high-concept; it’s virtual, since, he claims, the district would never have to enforce it. Drug companies would preemptively negotiate with the city to stay out of the courts, explains Catania. “They’ll do anything they possibly can to avoid discussing how they price their drugs,” he says. His constituents, meanwhile, would celebrate the bargains.

A BETTER WAY TO DO THIS?

We have an ambitious $350,000 online fundraising goal this month and we can't afford to come up short. But when a reader recently asked how being a nonprofit makes Mother Jones different from other news organizations, we realized we needed to lay this out better: Because "in absolutely every way" is essentially the answer.

So we tried to explain why your year-end donations are so essential, and we'd like your help refining our pitch about what make Mother Jones valuable and worth reading to you.

We'd also like your support of our journalism with a year-end donation if you can right now—all online gifts will be doubled until we hit our $350,000 goal thanks to an incredibly generous donor's matching gift pledge.

payment methods

A BETTER WAY TO DO THIS?

We have an ambitious $350,000 online fundraising goal this month and we can't afford to come up short. But when a reader recently asked how being a nonprofit makes Mother Jones different from other news organizations, we realized we needed to lay this out better: Because "in absolutely every way" is essentially the answer.

So we tried to explain why your year-end donations are so essential, and we'd like your help refining our pitch about what make Mother Jones valuable and worth reading to you.

We'd also like your support of our journalism with a year-end donation if you can right now—all online gifts will be doubled until we hit our $350,000 goal thanks to an incredibly generous donor's matching gift pledge.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate